Search

GlaxoSmithKline PLC

Suletud

SektorTervishoid

1,910 0.53

Ülevaade

Aktsiahinna muutus

24h

Praegune

Min

1855.5

Max

1911.5

Põhinäitajad

By Trading Economics

Sissetulek

-1.4B

435M

Müük

780M

8.4B

P/E

Sektori keskmine

15.691

57.371

Aktsiakasum

0.51

Dividenditootlus

3.74

Kasumimarginaal

5.173

Töötajad

66,841

EBITDA

-153M

2.6B

Soovitused

By TipRanks

Soovitused

Neutraalne

12 kuu keskmine prognoos

+12.09% upside

Dividendid

By Acuity

Dividenditootlus

Sektori keskmine

3.74%

2.23%

Järgmine tulemuste avaldamine

28. okt 2026

Järgmine dividendimakse kuupäev

8. okt 2026

Järgmine aktsia dividendi kuupäev (ex-date)

12. nov 2026

Turustatistika

By TradingEconomics

Turukapital

-4.4B

74B

Eelmine avamishind

1909.47

Eelmine sulgemishind

1910

Uudiste sentiment

By Acuity

25%

75%

73 / 340 Pingereas Healthcare

GlaxoSmithKline PLC Graafik

Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.

Seotud uudised

24. aug 2026, 23:46 UTC

News

PG&E Corp shares are lower in after-market hours despite announcing an expansion of its Vehicle to Everything program and analysts' fair value estimate of $22.59.

24. aug 2026, 23:46 UTC

News

DA Davidson initiated coverage of Vulcan Materials Co with a Buy rating. Shares traded higher in after-market hours following Monday's close of $276.04.

24. aug 2026, 23:46 UTC

News

Jack Henry & Associates appoints Richard N. Preece to its Board of Directors, effective August 20, 2026. Shares are higher in after-market trading.

24. aug 2026, 23:46 UTC

News

Parker-Hannifin Corp filed a mixed securities shelf to raise capital. Shares advanced in after-market trading, continuing a trend of higher daily closes.

24. aug 2026, 23:31 UTC

News
Social Media

Kura Oncology shares are higher in after-market hours following CEO Troy Wilson's $1.2 million stock purchase, boosting his ownership to 1.214 million shares.

24. aug 2026, 23:26 UTC

News

National Beverage Corp's shares are lower in after-market hours, despite recent strength and five consecutive higher closes, amid geopolitical concerns affecting market sentiment.

24. aug 2026, 23:21 UTC

News

USD/HKD is trading lower, impacted by a stronger U.S. Dollar and economic pressures from new sanctions on Iran. Limited fluctuations persist in the market.

24. aug 2026, 23:16 UTC

News

Trade Desk Inc's stock fell in after-hours trading following a prospectus filing for a mixed shelf offering of various securities. The company holds $1.12 billion in cash.

24. aug 2026, 23:16 UTC

News

Coinbase Global Inc shares declined in after-market trading following the company's integration of Chainlink for real-time pricing of tokenized stocks on Base.

24. aug 2026, 23:16 UTC

News

Diamondback Energy shares are lower in after-market hours amid concerns from CEO Van't Hof's recent insider selling of 10,000 shares at $214.66 each.

24. aug 2026, 23:11 UTC

News

Nasdaq Inc shares are trading lower in after-market hours, reflecting broader market declines driven by weakness in technology stocks and geopolitical tensions.

24. aug 2026, 23:11 UTC

News

Copart Inc shares are lower in after-market hours, reflecting unusual volatility amid broader market concerns over geopolitical tensions and economic disruptions.

24. aug 2026, 23:06 UTC

Event
News

Gilead Sciences gains after European approval for Trodelvy and raises 2026 sales guidance to $30.1–$30.4 billion, reflecting strong performance in HIV and oncology.

24. aug 2026, 23:01 UTC

Social Media
News

Re/Max Holdings Inc. announced a $450 million share repurchase authorization, contributing to a higher trading performance during after-market hours.

24. aug 2026, 23:01 UTC

News

Grand Canyon Education shares declined in after-market hours following CFO Daniel E. Bachus's placement on paid administrative leave amid an ongoing investigation.

24. aug 2026, 23:01 UTC

News

Herc Holdings shares rise in after-market trading following director Erik Olsson's $503K purchase of 3.1K shares, signaling potential confidence in the company.

24. aug 2026, 23:01 UTC

News

Tyson Foods announced a $1 million commitment to the Harvest to Hallways initiative, enhancing childhood nutrition and food access, contributing to positive sentiment.

24. aug 2026, 23:01 UTC

News

Oshkosh shares are higher in after-market trading following praise from Secretary of War Pete Hegseth for the company's defense manufacturing capabilities and tactical vehicles.

24. aug 2026, 23:01 UTC

News

Vistra Corp shares rose in after-market trading after CEO James Burke bought 2,000 shares for $270,000, increasing his total ownership to 1.235 million shares.

24. aug 2026, 22:51 UTC

News
Social Media

Boeing Co received a $131.23 billion contract for the F-15 Eagle Crest, with shares trading higher in after-market hours following the announcement.

24. aug 2026, 22:16 UTC

News

A federal court upheld an $83.4 million award against Guardant Health for patent infringement, though shares are trading higher in after-market hours.

24. aug 2026, 22:16 UTC

News

Kenneth S. Courtis bought $3.2 million in Alpha Metallurgical Resources shares, contributing to modest after-market gains following recent insider purchases.

24. aug 2026, 22:06 UTC

News

Peabody Energy shares are lower in after-market hours following a class action lawsuit alleging misleading statements about its Centurion mine operations.

24. aug 2026, 22:01 UTC

News

Savara Inc. will present Phase 3 trial results for molgramostim at the European Respiratory Society Congress in 2026. Shares are higher in after-market trading.

24. aug 2026, 21:41 UTC

News

Franklin Resources announces cash distributions for ETFs, with payments set for September 2026. Shares are trading higher in after-market hours following the news.

24. aug 2026, 21:02 UTC

News

DA Davidson initiated coverage of Advanced Drainage Systems with a Buy rating. Shares rose in after-market trading, closing at $143.73.

24. aug 2026, 21:01 UTC

News

Owens Corning shares rise in after-market trading following a Buy rating from DA Davidson analyst Garik Shmois. The stock closed at $148.06.

24. aug 2026, 20:07 UTC

Social Media
News

Uber Technologies has partnered with Zoomcar to offer intercity ride options in India. Shares are higher as the initiative launches in major cities.

24. aug 2026, 20:07 UTC

News
Correlated Moves
Social Media

NVIDIA Corp's stock is lower amid negative sentiment from a senior manager's indictment for alleged AI chip smuggling and rising costs for customers.

24. aug 2026, 20:07 UTC

News

Impinj Inc shares are lower amid pressure in the Semiconductors sector and concerns over licensing revenue from NXP. Adjusted EBITDA margin is 15%.

Võrdlus sarnastega

Hinnamuutus

GlaxoSmithKline PLC Prognoos

Hinnasiht

By TipRanks

12.09% tõus

12 kuu keskmine prognoos

Keskmine 2,119 GBX  12.09%

Kõrge 3,010 GBX

Madal 1,700 GBX

Põhineb 16 Wall Streeti analüütiku instrumendi GlaxoSmithKline PLC 12 kuu hinnasihil - viimase 3 kuu andmed.

Hinnangu Konsensus

By TipRanks

Neutraalne

16 ratings

3

Osta

10

Hoia

3

Müü

Sentiment

By Acuity

73 / 340 Pingereas Tervishoid

Uudiste sentiment

Väga tugevad tõusu märgid

Volatiilsus

Alla keskmise

Uudismaht (RCV)

Üle keskmise

Finantsandmed

Müügi- ja halduskulud

Tegevuskulud

Maksueelne kasum

Müük

Müügikulu

Brutokasum müügist

Intressikulud võla pealt

EBITDA

Ärikasum

$

Ettevõttest GlaxoSmithKline PLC

GSK plc, together with its subsidiaries, engages in the research, development, and manufacture of vaccines, and specialty and general medicines to prevent and treat disease in the United Kingdom, the United States, and internationally. It operates through two segments, Commercial Operations and Total R&D. The company offers shingles, meningitis, respiratory syncytial virus, flu, polio, influenza, and pandemic vaccines. It also provides medicines for HIV, oncology, respiratory/immunology, and other specialty medicine products, as well as inhaled medicines for asthma and chronic obstructive pulmonary disease, and antibiotics for infections. It has a collaboration agreement with CureVac to develop mRNA-based influenza vaccines, and with Wave Life Sciences and Elsie Biotechnologies, Inc for oligonucleotide platform development; two strategic collaborations with Relation to advance therapeutics for fibrotic diseases and osteoarthritis; and multi-target strategic alliance with GSK to develop breakthrough treatments for people afflicted with Parkinson's disease; as well as collaboration with Flagship Pioneering to discover novel medicines and vaccines. The company was formerly known as GlaxoSmithKline plc and changed its name to GSK plc in May 2022. GSK plc was founded in 1715 and is headquartered in Brentford, the United Kingdom.dom.
help-icon Live chat